Abstract:Colorectal cancer (CRC) is the third leading cause of cancer-related mortality in men or women in the United States. Average-risk screening that begins at age 50 years has reduced incidence and mortality of CRC in those over 50 years of age, whereas CRC incidence in those under age 50 years (early onset colorectal cancer (eoCRC)) has recently and dramatically increased. In this review, we summarize the recent literature including risk factors for eoCRC, differences in clinicopathologic presentation and outcomes in eoCRC, and emerging evidence regarding the molecular pathways that are altered in eoCRC compared to later onset CRC (loCRC). Epidemiologic studies of eoCRC show predominance in distal colon and rectum, and association with several modifiable risk factors, including diabetes, obesity, diet, sedentary time, alcohol consumption and smoking. Data regarding potential risk factors of prior antibiotic exposure and microbiome alterations or direct carcinogen exposure are still emerging. Aggressive clinicopathologic features of eoCRC at presentation may be due to delay in diagnosis or more aggressive tumor biology. EoCRC outcomes are similar to loCRC when matched for stage, but overall mortality is greater due to higher frequency of advanced disease at a younger presentation, with more life-years lost. There are only few molecular evaluations of eoCRC to date, with findings of potential increase in TP53 and CTNNB1 somatic mutation and decrease in APC, KRAS and BRAF somatic mutation, compared to loCRC. Other findings include LINE-1 hypomethylation, absence of microsatellite instability (MSI-H), presence of chromosomal instability (CIN) or microsatellite and chromosomal stability (MACS). These studies are only now emerging and have not yet identified a specific molecular signature defining eoCRC. Further research evaluating genetic and molecular differences as well as environmental triggers for eoCRCs should provide a clearer understanding to inform targeted screening for pre-symptomatic at-risk younger individuals.

[Emphasis on awareness of early-onset colorectal cancer]

Research Progress in Early-onset Colorectal Cancer

Early-onset colorectal cancer: Current insights and future directions

Early-Onset colorectal Cancer: From the laboratory to the clinic

Epidemiology and biology of early onset colorectal cancer

Early-onset colorectal cancer: initial clues and current views

Oncotherapeutic Strategies in Early Onset Colorectal Cancer

Early-Onset Colorectal Cancer in Patients under 50 Years of Age: Demographics, Disease Characteristics, and Survival

Comprehensive Analysis of Early-onset Colorectal Cancer: A Review

Causes and Prevention of Early-Onset Colorectal Cancer

Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer center

Unraveling the complexities of early-onset colorectal cancer: a perspective on dietary and microbial influences

Rising incidence of early-onset colorectal cancer — a call to action

Challenges around diagnosis of early onset colorectal cancer, and the case for screening

Differences in characteristics and outcomes between early-onset colorectal cancer and late-onset colorectal cancers

Field synopsis of environmental and genetic risk factors of sporadic early-onset colorectal cancer and advanced adenoma.

Obesity and early-onset colorectal cancer risk: emerging clinical evidence and biological mechanisms

Early-Onset Colorectal Cancer: Current Insights

Advances in Epigenetic Biomarker Research in Colorectal Cancer.

The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment

Behavioral Risk Factors and Risk of Early-Onset Colorectal Cancer: Review of the Mechanistic and Observational Evidence